As researchers that have supported building evidence around contraceptive safety, effectiveness and interests, we were thrilled when the U.S. Food and Drug Administration (FDA) announced they had approved Opill - a progestin-only pill (POP) - for over-the-counter use.
Finally, after decades of advocacy and research, birth control pills will soon be accessible without a prescription for people of all ages in the United States. As we mark World Contraception Day, we're closer than ever to breaking down barriers to contraception. Opill is expected to be on the shelves in early 2024 at pharmacies, retail stores and available online — and it will be a gamechanger for contraceptive access nationwide.
